Home Articles List Article Information
Alexandria Dental Journal
Journal Archive
Volume Volume 49 (2024)
Volume Volume 48 (2023)
Volume Volume 47 (2022)
Volume Volume 46 (2021)
Volume Volume 45 (2020)
Volume Volume 44 (2019)
Volume Volume 43 (2018)
Volume Volume 42 (2017)
Volume Volume 41 (2016)
Volume Volume 40 (2015)
Eissa, A., Karam, S., Omar, S., Sayed, M. (2018). EFFECT OF AUTOGENOUS BONE MARROW MESENCHYMAL STEM CELLS IN HEALING OF MANDIBULAR OSSEOUS DEFECTS GRAFTED WITH BETA TRICALCIUM PHOSPHATE IN DOGS. Alexandria Dental Journal, 43(3), 48-52. doi: 10.21608/adjalexu.2018.57993
Amira S. Eissa; Sahar Sh. Karam; Samia S. Omar; Mohamed I. Sayed. "EFFECT OF AUTOGENOUS BONE MARROW MESENCHYMAL STEM CELLS IN HEALING OF MANDIBULAR OSSEOUS DEFECTS GRAFTED WITH BETA TRICALCIUM PHOSPHATE IN DOGS". Alexandria Dental Journal, 43, 3, 2018, 48-52. doi: 10.21608/adjalexu.2018.57993
Eissa, A., Karam, S., Omar, S., Sayed, M. (2018). 'EFFECT OF AUTOGENOUS BONE MARROW MESENCHYMAL STEM CELLS IN HEALING OF MANDIBULAR OSSEOUS DEFECTS GRAFTED WITH BETA TRICALCIUM PHOSPHATE IN DOGS', Alexandria Dental Journal, 43(3), pp. 48-52. doi: 10.21608/adjalexu.2018.57993
Eissa, A., Karam, S., Omar, S., Sayed, M. EFFECT OF AUTOGENOUS BONE MARROW MESENCHYMAL STEM CELLS IN HEALING OF MANDIBULAR OSSEOUS DEFECTS GRAFTED WITH BETA TRICALCIUM PHOSPHATE IN DOGS. Alexandria Dental Journal, 2018; 43(3): 48-52. doi: 10.21608/adjalexu.2018.57993

EFFECT OF AUTOGENOUS BONE MARROW MESENCHYMAL STEM CELLS IN HEALING OF MANDIBULAR OSSEOUS DEFECTS GRAFTED WITH BETA TRICALCIUM PHOSPHATE IN DOGS

Article 8, Volume 43, Issue 3, December 2018, Page 48-52  XML PDF (1022.46 K)
Document Type: Original Article
DOI: 10.21608/adjalexu.2018.57993
View on SCiNiTO View on SCiNiTO
Authors
Amira S. Eissa1; Sahar Sh. Karam2; Samia S. Omar3; Mohamed I. Sayed4
1Assistant lecturer of Oral Biology - Faculty of Dentistry - Alexandria University.
2Professor and Head of Oral Biology Department - Faculty of Dentistry - Alexandria University
3Professor of Oral Biology Department - Faculty of Dentistry - Alexandria University
4Professor of Clinical Pathology Department - Faculty of Medicine - Alexandria University
Abstract
INTRODUCTION: Bone defect above critical size does not heal completely by itself and thus represents major clinical challenge to reconstructive surgery. Tissue engineering is a new approach for the repair of osseous defects. β tricalcium phosphate (β-TCP) loaded with autogenous bone marrow derived mesenchymal stem cells (BMSCs) is suggested to have a promising osteogenic characteristics that support its potential in tissue engineering to repair bone defects. OBJECTIVES: was to evaluate the efficacy of autogenous (BMSCs) by its transplantation into local defects using (β-TCP) as a carrier. MATERIALS AND METHODS: Ten male Mongrel dogs weighing 25 Kg were used in this study. Right and critical size bone defects (CSDs) were performed intraorally at the mandibular premolar area by the aid of trephine bur, of 6mm outer diameter and 5mm inner diameter. Right side bone defects (Experimental) were filled with mixture of (β-TCP) and (BMSCs) which was taken from bone marrow aspirate concentrates (BMACs) from the same animal. Meanwhile, the left side bone defects (control) were left empty for healing spontaneously. The effect of (BMSCs) was assessed histologically as well as histomorphometrically after 6 weeks. RESULTS Greater amount of bone formation was noticed in (CSDs) filled with (β-TCP) and (BMSCs). The amounts of new bone formed in the defects filled with (β-TCP) and (BMSCs) were significantly greater than those formed within the defects that were left empty. CONCLUSIONS: Autogenous (BMSCs) has excellent osteogenic characteristics and can be added to bone grafts following surgical and periodontal surgeries to enhance bone regenerative capacity.
Keywords
antifungal activity; Candida albicans; photocatalytic nano-titanium dioxide; silicone elastomer
Main Subjects
Oral biology
References
  1. Shayesteh YS, Khojasteh A, Soleimani M, Alikhasi M, Khoshzaban A, Ahmadbeigi N. Sinus augmentation using human mesenchymal stem cells loaded into a β-tricalcium phosphate/hydroxyapatite scaffold. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2008; 106(2):203-9.
  2. Poser L, Matthys R, Schawalder P, Pearce S, Alini M, Zeiter S. A standardized critical size defect model in normal and osteoporotic rats to evaluate bone tissue engineered constructs. Biomed Res Int. 2014; 2014.
  3. Suenaga H, Furukawa KS, Suzuki Y, Takato T, Ushida T. Bone regeneration in calvarial defects in a rat model by implantation of human bone marrow-derived mesenchymal stromal cell spheroids. J Mater Sci Mater Med. 2015; 26(11):1-9.
  4. Delloye C, Cornu O, Druez V, Barbier O. Bone allografts. J Bone Jt Infect. 2007;89(5):574-80.
  5. Haynesworth S, Goshima J, Goldberg V, Caplan A. Characterization of cells with osteogenic potential from human marrow. Bone. 1992; 13(1):81-8.
  6. Boo JS, Yamada Y, Okazaki Y, Hibino Y, Okada K, Hata K-I, et al. Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg. 2002;13(2):231-9.
  7. Heng BC, Cao T, Stanton LW, Robson P, Olsen B. Strategies for directing the differentiation of stem cells into the osteogenic lineage in vitro. J Bone Miner Res. 2004; 19(9):1379-94.
  8. Vahabi S, Amirizadeh N, Shokrgozar M, Mofeed R, Mashhadi A, Aghaloo M, et al. A comparison between the efficacy of Bio-Oss, hydroxyapatite tricalcium phosphate and combination of mesenchymal stem cells in inducing bone regeneration. Chang Gung Med J. 2011; 35(1):28-37.
  9. Wei X, Yang X, Han Z-p, Qu F-f, Shao L, Shi Y-f. Mesenchymal stem cells: a new trend for cell therapy. Acta Pharmacol Sin. 2013;34(6):747-54.
  10. Bose S, Roy M, Bandyopadhyay A. Recent advances in bone tissue engineering scaffolds. Trends Biotechnol. 2012;30(10):546-54.
  11. Arinzeh TL, Peter SJ, Archambault MP, Van Den Bos C, Gordon S, Kraus K, et al. Allogeneic mesenchymal stem cells regenerate bone in a critical-sized canine segmental defect. J Bone Joint Surg Am. 2003;85(10):1927-35.
  12. Šponer P, Kučera T, Diaz-Garcia D, Filip S. The role of mesenchymal stem cells in bone repair and regeneration. Eur J Orthop Surg Traumatol. 2014;24(3):257-62.
  13. Yang L, Sun H-Y, Qi N-M, Tan W-S. The effects of βtricalcium phosphate 3D scaffold in-situ cryopreservation on the migration rate and osteogenic ability of mesenchymal stem cells. Bioresour Bioprocess. 2012;17(1):195-202.
  14. Matsushima A, Kotobuki N, Tadokoro M, Kawate K, Yajima H, Takakura Y, et al. In Vivo Osteogenic Capability of Human Mesenchymal Cells Cultured on Hydroxyapatite and on β‐Tricalcium Phosphate. Artif Organs. 2009; 33(6):474-81.
  15. Umeda H, Kanemaru Si, Yamashita M, Kishimoto M, Tamura Y, Nakamura T, et al. Bone Regeneration of Canine Skull Using Bone Marrow‐Derived Stromal Cells and β‐ Tricalcium Phosphate. Laryngoscope. 2007; 117(6):997- 1003.
  16. Warren SM, Nacamuli RK, Song HM, Longaker MT. Tissue-engineered bone using mesenchymal stem cells and a biodegradable scaffold. J Craniofac Surg. 2004;15(1):34- 7.
  17. Russmueller G, Moser D, Spassova E, Plasenzotti R, Poeschl P, Seemann R, et al. Tricalcium phosphate-based biocomposites for mandibular bone regeneration—A histological study in sheep. J Craniomaxillofac Surg. 2015;43(5):696-704.
  18. Nakagawa Y, Muneta T, Tsuji K, Ichinose S, Hakamatsuka Y, Koga H, et al. β-Tricalcium phosphate micron particles enhance calcification of human mesenchymal stem cells in vitro. J Nanomater. 2013; 2013:5.
  19. Wang XL, Xie XH, Zhang G, Chen SH, Yao D, He K, et al. Exogenous phytoestrogenic molecule icaritin incorporated into a porous scaffold for enhancing bone defect repair. J Orthop Res. 2013; 31(1):164-72.
  20. Brennan MÁ, Renaud A, Amiaud J, Rojewski MT, Schrezenmeier H, Heymann D, et al. Pre-clinical studies of bone regeneration with human bone marrow stromal cells and biphasic calcium phosphate. Stem Cell Res Ther. 2014; 5(5):1.
Statistics
Article View: 202
PDF Download: 441